Try our Advanced Search for more refined results
Searching dockets in Jazz Pharmaceuticals Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Set/Reset Motion and R&R Deadlines/Hearings
Set Deadlines as to 36 Joint MOTION to Seal Document 28 Letter,, . Motion set for 8/3/2026 before Magistrate Judge Leda D. Wettre. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (mj)
Qui Tam (31 U.S.C. § 3729(a)) | New York Southern
Declaration in Support of Motion
DECLARATION of Matthew C. Bergs, Esq. in Support re: 24 MOTION to Dismiss First Amended Complaint.. Document filed by Jazz Pharmaceuticals Inc., Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals PLC.. (Attachments: # 1 Exhibit 1 - 2005 Xyrem Label, # 2 Exhibit 2 - 2012 Xyrem Label, # 3 Exhibit 3 - 2012 FDA Drug Safety Communication, # 4 Exhibit 4 - 2016 Jazz FDA Citizen Petition, # 5 Exhibit 5 - Jazz POPR (Par IPR), # 6 Exhibit 6 - Eller DDI Study, # 7 Exhibit 7 - File History of U.S. Patent No. 8,772,306, # 8 Exhibit 8 - U.S. Patent No. 8,772,306, # 9 Exhibit 9 - 2014 Xyrem Label, # 10 Exhibit 10 - 2016 Par Response to Jazz Citizen Petition, # 11 Exhibit 11 - 2017 Citizen Petition Approval Letter, # 12 Exhibit 12 - Par IPR Petition, # 13 Exhibit 13 - Ranbaxy IPR Petition, # 14 Exhibit 14 - Amneal IPR Petition, # 15 Exhibit 15 - Institution Decision (Par IPR), # 16 Exhibit 16 - Institution Decision (Amneal IPR), # 17 Exhibit 17 - Institution Decision (Ranbaxy IPR), # 18 Exhibit 18 - Termination of Proceeding (Ranbaxy IPR), # 19 Exhibit 19 - U.S. Patent No. 10,213,400, # 20 Exhibit 20 - U.S. Patent No. 10,864,181, # 21 Exhibit 21 - 2006 Pardi & Black, # 22 Exhibit 22 - 2015 Winegarner Article (Law360), # 23 Exhibit 23 - 2018 Mealey's Litig. Article, # 9296 additional result(s)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.